文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

成人社区获得性肺炎诊断和治疗。美国胸科学会和美国传染病学会的官方临床实践指南。

Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America.

出版信息

Am J Respir Crit Care Med. 2019 Oct 1;200(7):e45-e67. doi: 10.1164/rccm.201908-1581ST.


DOI:10.1164/rccm.201908-1581ST
PMID:31573350
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6812437/
Abstract

This document provides evidence-based clinical practice guidelines on the management of adult patients with community-acquired pneumonia. A multidisciplinary panel conducted pragmatic systematic reviews of the relevant research and applied Grading of Recommendations, Assessment, Development, and Evaluation methodology for clinical recommendations. The panel addressed 16 specific areas for recommendations spanning questions of diagnostic testing, determination of site of care, selection of initial empiric antibiotic therapy, and subsequent management decisions. Although some recommendations remain unchanged from the 2007 guideline, the availability of results from new therapeutic trials and epidemiological investigations led to revised recommendations for empiric treatment strategies and additional management decisions. The panel formulated and provided the rationale for recommendations on selected diagnostic and treatment strategies for adult patients with community-acquired pneumonia.

摘要

本文件提供了有关成人社区获得性肺炎管理的循证临床实践指南。一个多学科小组对相关研究进行了实用系统评价,并为临床建议应用了推荐分级的评估、制定与评价方法。小组针对涵盖诊断检测、护理场所确定、初始经验性抗生素治疗选择以及后续管理决策等问题的 16 个具体领域提出了建议。尽管一些建议与 2007 年指南保持不变,但新治疗试验和流行病学研究的结果导致经验性治疗策略和其他管理决策的建议发生了修订。小组为成人社区获得性肺炎患者的选定诊断和治疗策略制定了建议,并提供了建议的基本原理。

相似文献

[1]
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America.

Am J Respir Crit Care Med. 2019-10-1

[2]
The hospitalist perspective on treatment of community-acquired bacterial pneumonia.

Postgrad Med. 2014-3

[3]
Diagnosis and management of community-acquired pneumonia in adults.

Am Fam Physician. 2011-6-1

[4]
[Comparative analysis of guidelines for the treatment of community-acquired pneumonias].

Arch Bronconeumol. 1999-6

[5]
[Management of community-acquired pneumonia in the physician's office].

MMW Fortschr Med. 2006-1-12

[6]
Emergency management of community-acquired bacterial pneumonia: what is new since the 2007 Infectious Diseases Society of America/American Thoracic Society guidelines.

Am J Emerg Med. 2013-2-4

[7]
Atypical pneumonia.

Curr Opin Pulm Med. 2014-5

[8]
Coverage of atypical pathogens for hospitalised patients with community-acquired pneumonia is not guided by clinical parameters.

Swiss Med Wkly. 2013-9-19

[9]
Real life management of community-acquired Pneumonia in adults in the Gulf region and comparison with practice guidelines: a prospective study.

BMC Pulm Med. 2015-9-30

[10]
Validation of sputum Gram stain for treatment of community-acquired pneumonia and healthcare-associated pneumonia: a prospective observational study.

BMC Infect Dis. 2014-10-18

引用本文的文献

[1]
Outcomes associated with use of makyokansekito, a Japanese herbal kampo medicine, in outpatients with community-acquired pneumonia: A retrospective cohort study.

J Gen Fam Med. 2025-7-27

[2]
Omadacycline in the treatment of severe Q fever pneumonia during an influenza epidemic: a case report with literature review.

Front Med (Lausanne). 2025-8-18

[3]
Doxycycline for Pneumonia: Expanding Treatment Horizons Through a Case Series and Narrative Review.

J Pharm Technol. 2025-8-31

[4]
Evaluation of Diagnostic Efficacy of Targeted Next-Generation Sequencing on Nasopharyngeal Swabs in Pediatric Community-Acquired Pneumonia.

Int J Gen Med. 2025-8-27

[5]
Time-Lagged Effects of Hyperglycemia on Inflammation in Older Adults with Community-Acquired Pneumonia: Nutritional Insights and Personalized Intervention Windows.

Clin Interv Aging. 2025-8-25

[6]
Comparative Prognostic Accuracy of Clinical and Inflammation- or Nutrition-Based Scores in Older Adults with Community-Acquired Pneumonia.

Int J Gen Med. 2025-8-27

[7]
An antibiotic stewardship initiative focused on community-acquired bacterial pneumonia (CABP) in outpatient clinics and urgent care centers: a 2023-2024 community health system experience.

Antimicrob Steward Healthc Epidemiol. 2025-8-15

[8]
The bacterial etiology and antimicrobial susceptibility of lower respiratory tract infections in Vietnam.

Ann Clin Microbiol Antimicrob. 2025-8-31

[9]
Divergent biological pathways distinguish community-acquired pneumonia from COVID-19 despite similar plasma cytokine profiles.

Respir Res. 2025-8-31

[10]
The impact of pt-NGS technology on antimicrobial use and outcomes in patients with lower respiratory tract infections: a hospital-based real-world study.

BMC Infect Dis. 2025-8-28

本文引用的文献

[1]
Omadacycline for Community-Acquired Bacterial Pneumonia.

N Engl J Med. 2019-2-7

[2]
Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial.

Clin Infect Dis. 2019-11-13

[3]
Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa.

Clin Infect Dis. 2019-3-5

[4]
Systematic Review and Meta-analysis of the Efficacy of Short-Course Antibiotic Treatments for Community-Acquired Pneumonia in Adults.

Antimicrob Agents Chemother. 2018-8-27

[5]
Burden and risk factors for community-acquired pneumonia: a multinational point prevalence study of hospitalised patients.

Eur Respir J. 2018-8-9

[6]
Low procalcitonin, community acquired pneumonia, and antibiotic therapy.

Lancet Infect Dis. 2018-5

[7]
The Clinical Utility of Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Screening to Rule Out MRSA Pneumonia: A Diagnostic Meta-analysis With Antimicrobial Stewardship Implications.

Clin Infect Dis. 2018-6-18

[8]
Corticosteroids in Patients Hospitalized With Community-Acquired Pneumonia: Systematic Review and Individual Patient Data Metaanalysis.

Clin Infect Dis. 2018-1-18

[9]
Clinical predictors of methicillin-resistant Staphylococcus aureus in nosocomial and healthcare-associated pneumonia: a multicenter, matched case-control study.

Eur J Clin Microbiol Infect Dis. 2017-9-8

[10]
The respiratory threat posed by multidrug resistant Gram-negative bacteria.

Respirology. 2017-10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索